Extensive European study finds very high rates of long-COVID Coronavirus Disease COVID Depression Fatigue Headache LongCOVID PASC ecdc_eu
To make it easier to document clinical side effects following severe acute respiratory syndrome coronavirus 2 infection, the World Health Organization developed the International Classification of Disease codes in September 2020. The WHO used the Delphi approach to produce a consolidated clinical case definition, using the terminology "post-COVID-19 condition" in response to the wide variety of symptom constellations included in the various definitions for "long COVID.
Preferred Reporting Items for Systematic Reviews and Meta-Analysis and Meta-analyses Of Observational Studies in Epidemiology protocols were used for conducting the present systematic review. This meta-main analysis estimated the prevalence of post-COVID-19 condition symptoms as a proxy for illness severity, classified according to recruitment setting into community, hospital, and intensive care units .
Related StoriesThe degree of certainty in the evidence obtained for each relevant outcome was assessed using the Grading of Recommendations Assessment, Development, and Evaluation . According to GRADE recommendations, all study outcomes were given an initial score of high certainty before being rated down for flaws like inconsistency, evidence of publication bias, indirectness or inaccuracy of results, or rated up for methodologically robust studies with significant observed effects.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The impact of genetic and lifestyle factors on the risk of major cardiovascular and thromboembolic events post-COVID-19 diagnosisThe impact of genetic and lifestyle factors on the risk of major cardiovascular and thromboembolic events post-COVID-19 diagnosis medrxivpreprint UniofOxford LSHTM Cambridge_Uni ErasmusMC
Read more »
Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study - Critical CareBackground The study aimed to describe the epidemiology and outcomes of hospital-acquired bloodstream infections (HABSIs) between COVID-19 and non-COVID-19 critically ill patients. Methods We used data from the Eurobact II study, a prospective observational multicontinental cohort study on HABSI treated in ICU. For the current analysis, we selected centers that included both COVID-19 and non-COVID-19 critically ill patients. We performed descriptive statistics between COVID-19 and non-COVID-19 in terms of patients’ characteristics, source of infection and microorganism distribution. We studied the association between COVID-19 status and mortality using multivariable fragility Cox models. Results A total of 53 centers from 19 countries over the 5 continents were eligible. Overall, 829 patients (median age 65 years [IQR 55; 74]; male, n = 538 [64.9%]) were treated for a HABSI. Included patients comprised 252 (30.4%) COVID-19 and 577 (69.6%) non-COVID-19 patients. The time interval between hospital admission and HABSI was similar between both groups. Respiratory sources (40.1 vs. 26.0%, p | 0.0001) and primary HABSI (25.4% vs. 17.2%, p = 0.006) were more frequent in COVID-19 patients. COVID-19 patients had more often enterococcal (20.5% vs. 9%) and Acinetobacter spp. (18.8% vs. 13.6%) HABSIs. Bacteremic COVID-19 patients had an increased mortality hazard ratio (HR) versus non-COVID-19 patients (HR 1.91, 95% CI 1.49–2.45). Conclusions We showed that the epidemiology of HABSI differed between COVID-19 and non-COVID-19 patients. Enterococcal HABSI predominated in COVID-19 patients. COVID-19 patients with HABSI had elevated risk of mortality. Trial registration ClinicalTrials.org number NCT03937245 . Registered 3 May 2019.
Read more »
Italian study evaluates COVID-19 reinfection risk among previously infected and vaccinated individualsItalian study evaluates COVID-19 reinfection risk among previously infected and vaccinated individuals UniAvogadro researchsquare COVID19 SARSCoV2 Vaccination Infection
Read more »
Covid experts give predictions for Christmas as two new strains found in UKFOR the first times in years Britain could experience a relatively Covid-free Christmas this winter, despite the emergence of two new variants. Modelling by University College London (UCL) suggests…
Read more »
China’s Covid Strategy Is Keeping Oil Prices In Check | OilPrice.comWhile oil prices recorded their first monthly gain in four months in October, China’s zero-Covid strategy is keeping industrial activity suppressed and reducing the country’s oil demand
Read more »